Why is this webinar a must for healthcare professionals?
Did you know that’healthcare industry is the 3ᵉ die to benefit from the Research Tax Credit ? In 2021, it represented 759 M€ receivable, or 11.1 % of total national receivables (source: MESR). Visit CIR is therefore a a major source of funding for R&D in the sector.
But you still need to know which studies and activities are really eligible in a context of tightened tax controls and the Finance Act 2025, which restricts the basis for calculating the scheme...
Why take part in this webinar?
Clinical and epidemiological studies and the development of medical devices raise many questions about their eligibility for the CIR. The boundaries between eligible and ineligible activities are sometimes blurred, and mistakes can be costly.
In this webinar, our experts will help you to sorting out the truth from the falsehood and adopt a clear methodology for secure your CIR declarations and make it a sustainable lever for financing your R&D.
In the program :
- Conditions of eligibility for your clinical trials (phases I to IV), epidemiological studies and development of your medical devices.
- Focus on eligible and non-eligible activities (protocol, feasibility, recruitment, data collection and processing).
- Eligibility criteria for personnel involved (researchers, clinicians, data managers, etc.).
- Best practices for securing your CIR thanks to an analysis of legal texts, the CIR Guide and our feedback.
A question and answer session will close the presentation. You can submit your questions via the registration form.
Watch the replay of our webinar!
Who is this webinar for?
This webinar is aimed at all players in healthcare innovation, whether R&D and Innovation departments, clinical, regulatory or medical teams, or even financial managers, tax specialists and CIR managers. It concerns both startups that SMEs, ETIs and large groups sectors of the pharmaceuticals and biotechnologies, medical devices.
Clarify your areas of uncertainty, secure your projects and exchange ideas with healthcare CIR experts.
Reserve your free place now!
Conference hosted by :
Amandine LIGNIER - Manager, Innovation Consulting, G.A.C. Group
François-Xavier PIC - Head of Tax Law at G.A.C. Group
With a degree in chemistry and a PhD in biology, Amandine has been working in research funding since 2011. She has acquired extensive expertise in CIR for companies - particularly in the healthcare sector (pharmaceutical industries, biotechs, CROs...) - and supports them, alongside her team of consultants, in calculating and justifying their R&D expenditure, as well as in the answers and arguments to provide in their exchanges with the tax authorities.
François-Xavier holds a Master's degree in Private Law and a specialized Master's degree in "Juriste et Management International", and has been developing his expertise in research taxation for the past ten years. Today, he is head of the Innovation Tax Business Unit at G.A.C., where he is constantly on the lookout for new developments (legislation, case law, administrative doctrine), and assists his clients when they are faced with tax audits.
Newsletter
Receive all our expert news by e-mail.
Subscribe to our newsletter.
